Skip to main content
. 2021 Jul 31;3:100031. doi: 10.1016/j.lana.2021.100031

Table 3.

Interventions considered

Intervention Assumed Magnitude
Reduced Prescribing for Acute Pain 10% reduction in incidence of prescribing opioids for acute pain
Reduced Prescribing for Transitioning Pain 10% reduction in incidence of prescribing opioids for acute pain that transitions to chronic
Reduced Prescribing for Chronic Pain 10% reduction in incidence of prescribing opioids for chronic pain
Drug Rescheduling 10% reduction in chance of getting prescription renewed
Prescription Monitoring Program (PMP) 15% reduction in incidence of prescribing opioids for acute pain
5% reduction in incidence of prescribing opioids for transitioning pain
5% reduction in incidence of prescribing opioids for chronic pain
Drug Reformulation 2.25% reduction in iatrogenic use disorder
2.25% reduction in chance of use disorder via diversion for pain-free non-users
2.25% reduction in pill-seeking for individuals with SOUD without Rx
Excess Opioid Disposal - Policy 1 10% reduction in diversion to pain-free non-users
10% reduction in number of individuals with SOUD without Rx able to be sustained by non-SOUD Rx holders
Excess Opioid Disposal - Policy 2 15% reduction in diversion to pain-free non-users
15% reduction in number of individuals with SOUD without Rx able to be sustained by non-SOUD Rx holders
Naloxone Availability - Policy 1 5% reduction in overdose mortality
Naloxone Availability - Policy 2 15% reduction in overdose mortality
Naloxone Availability - Policy 3 30% reduction in overdose mortality
Pharmacotherapy 25% increased likelihood of entering pharmacotherapy
Psychosocial Treatment 10% increased likelihood of desistance
Syringe Exchange 10% reduction in infection mortality

Abbreviations: Rx = prescription; SOUD = severe opioid use disorder